This is just my basic MONTHLY charting. I have marked what I see as the POSSIBLE bottom (support). I see overall DOWNTREND with possible reversal. I have marked my potential BUY LEVELS for LONGS//CALLS.
As one of few micro-cap with real revenues (40% growth) blessed with huge market potential and very competent managment, I suspect the company will be bought out by one of the SPACs with too much cash but no real business. Patience is likely to be rewarded handsomely. Volumes have been tripling for days, a prelude to some excitement to come?
After basing for many years, CDXC is showing signs of awakening. Stocks are being accumulated but not aggressively. It's one of few bio stocks with insider buying at the current price. The co is likely on track doing $200 mil revenue in 2 or 3 years, 10X of the 200 mil revenue = 2 bil market cap, with about 62 mil shares O/S. Potentially huge valuation...
In this market where SPEC trades at billions with NO revenue, I like CDXC though I may be early. Yes it's not TSLA, yes Value does not work in this market but With a tiny market cap of 290 mil and revenue growth at 40% (still early-stage market), I am betting with Li Ka Shing, one of the richest and other top 20 institutions including Blackrock who collectively...